Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: An overview of the evidence from randomised trials

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 11, 1996, Pages 1085-1091

  Chien, Patrick F W ^a   Khan, Khalid S ^a   Arnott, Neil ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; MAGNESIUM SULFATE; PHENYTOIN;

ANTICONVULSANT THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; ECLAMPSIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; PREECLAMPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE;

ANTICONVULSANTS; DOUBLE-BLIND METHOD; ECLAMPSIA; FEMALE; HUMANS; MAGNESIUM SULFATE; MATERNAL MORTALITY; OBSERVER VARIATION; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TOCOLYTIC AGENTS; TREATMENT OUTCOME;

EID: 0029831735     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09587.x     Document Type: Article

References (33)

1. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Carribean. Br J Obstet Gynaecol 1992; 99: 547–553.
2. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1988–1990. London : HMSO, 1994:16–24.
3. Hutton ID, James DK, Stirrat GM, Douglas KA, Redman CWG. Management of severe pre-eclampsia and eclampsia by UK consultants. Br J Obstet Gynaecol 1992; 99: 554–556.
4. Sibai BM. Magnesium sulphate is the ideal anticonvulsant in preeclampsia/eclampsia. Am J obstet Gynecol 1990; 163:1689–1712.
5. Neilson P. Magnesium sulphate: the drug of choice in eclampsia. BMJ 1995; 311: 702–703.
6. Roberts JM. Magnesium for pre-eclampsia and eclampsia. N Engl J Med 1995; 333:250–251.
7. Saunders N. Magnesium for eclampsia. Lancet 1995; 346:788–789.
8. Cochrane Pregnancy and Childbirth Database. Cochrane updates on disk, Issue 1. London : BMJ Publishing Group, 1995.
9. Grant JM. Randomised trials and the British Journal of Obstetrics and Gynaecology. Br J Obstet Gynaecol 1995; 102:849–850.
10. Schultz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408–412.
11. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995; 16: 62–73.
12. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psycho1 Bull 1968; 70: 213–220.
13. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Znst 1959; 22: 719–748.
15. Breslow NE, Day NE. Statistical Methods in Cancer Research, Yo1 1. The Analysis of Case Control Studies. Lyon, France : LARC Scientific Publications, 1980.
16. Walss, Rodriguez RJ, Levario AR. Anticonvulsant treatment of severe preeclampsia. Comparison of diazepam and magnesium sulphate. Ginecol Obstet Mex 1992; 60: 331–335.
17. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence kom the Collaborative Eclampsia Trial. Lancet 1995; 345:1455–1463.
18. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990; 97:104–109.
19. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomised controlled trial. Br J Obstet Gynaecol 1990; 97:110–117.
20. Bhalla AK, Dhall GI, Dhall K. A safer and more effective treatment regimen for eclampsia. Aust N Z J Obstet Gynaecol 1994; 34: 144–148.
21. Lucas MJ, Beno KJ, Cunningham FG. A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333:201–205.
22. Friedman SA, Lim KH, Baker CA, Repke JT. Phenytoin versus magnesium sulphate in preeclampsia: a pilot study. Am J Perinatol 1993; 10:233–238.
23. Appleton MP, Kuehl TJ, Raebel MA, Adams HR, Knight AB, Gold WR. Magnesium sulphate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 165: 907–913.
24. Chen FP, Chang SD, Chu KK. Expectant management in severe pre-eclampsia: does magnesium sulphate prevent the development of eclampsia Acta Obstet Gynecol Scand 1995; 74 181–185.
25. Deshmukh M, Rajwade A, Wake D, Kutty V, Kudtarkar R. Preliminary report on the use of magnesium sulphate in cases of severe pre-eclampsia and eclampsia. J Postgrad Med 1985; 34: 199–202.
26. Belfort MA, Saade GR, Moise Jr W. The effect of magnesium sulphate on maternal retinal blood flow in pre-eclampsia: a randomised placebo-controlled study. Am J Obstet Gynecol 1992; 167: 1548–1553.
27. Belfort MA, Moise KJ. Effect of magnesium sulphate on maternal brain blood flow in pre-eclampsia: A randomised, placebo-controlled study. Am J Obstet Gynecol 1992; 167: 661–666.
28. Maheshwari JR, Desai SV, Hansotia MD, Walvekar VR. Anti-convulsant therapy in eclampsia. J Postgrad Med 1989; 35:66–99.
29. Sibai BM, Lipshitz J, Anderson GD, Dilts Jr PV. Reassessment of intravenous MgSO, therapy in pre-eclampsideclampsia. Obstet Gynecol 1981; 57: 199–202.
30. Ciuyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DL, Cook RJ. Users' guide to the medical literature. M. A method for grading health care recommendations. JAMA 1995; 274:1800–1804.
31. Duley L, Johanson R. Magnesium sulphate for pre-eclampsia and eclampsia: the evidence so far. Br J Obstet Gynaecol 1994; 101: 565–567.
32. Burrows RF, Burrows EA. The feasibility of a control population for a randomised control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J obstet Gynecol 1995; 173:929–935.
33. Smith GD, Egger N. Who benefits from medical interventions BMJ 1993; 308:72–74.